Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Mol Psychiatry ; 20(3): 353-60, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24798585

RESUMEN

Cholinergic neurons of the medial forebrain are considered important contributors to brain plasticity and neuromodulation. A reduction of cholinergic innervation can lead to pathophysiological changes of neurotransmission and is observed in Alzheimer's disease. Here we report on six patients with mild to moderate Alzheimer's disease (AD) treated with bilateral low-frequency deep brain stimulation (DBS) of the nucleus basalis of Meynert (NBM). During a four-week double-blind sham-controlled phase and a subsequent 11-month follow-up open label period, clinical outcome was assessed by neuropsychological examination using the Alzheimer's Disease Assessment Scale-cognitive subscale as the primary outcome measure. Electroencephalography and [(18)F]-fluoro-desoxyglucose positron emission tomography were, besides others, secondary endpoints. On the basis of stable or improved primary outcome parameters twelve months after surgery, four of the six patients were considered responders. No severe or non-transitional side effects related to the stimulation were observed. Taking into account all limitations of a pilot study, we conclude that DBS of the NBM is both technically feasible and well tolerated.


Asunto(s)
Enfermedad de Alzheimer/terapia , Núcleo Basal de Meynert/fisiología , Estimulación Encefálica Profunda/métodos , Resultado del Tratamiento , Anciano , Enfermedad de Alzheimer/diagnóstico , Electroencefalografía , Femenino , Fluorodesoxiglucosa F18/farmacocinética , Estudios de Seguimiento , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas , Tomografía de Emisión de Positrones , Escalas de Valoración Psiquiátrica , Calidad de Vida
2.
Z Gerontol Geriatr ; 48(7): 619-24, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25877770

RESUMEN

BACKGROUND: Anemia and hypoalbuminemia (HA) are acknowledged independent risk factors for morbidity and mortality in geriatric patients and are associated with nutritional status and frailty. Data exist regarding the association between albumin and frailty, anemia and frailty as well as frailty and nutritional status; however, there is a lack of information on the association between HA, anemia and nutritional status in older people. PATIENTS AND METHODS: This study retrospectively analyzed 626 patients admitted to a German geriatrics department (average age 81.1 years, 68.2% female and 31.8% male) for anemia and HA. Data from the comprehensive geriatric assessment (CGA) and from the mini-nutritional assessment (MNA) were available in all patients. RESULTS: Patients with anemia suffered significantly more often from HA (p<0.001) than patients without anemia, with an odds ratio (OR) of 1.99 (95% confidence interval CI: 1.2-3.2) and of 5.41 (CI 95%: 2.3-12.6) in patients at risk for malnutrition and in malnourished patients, respectively. A moderately significant association was seen between hemoglobin (Hb) and albumin values (Pearson's correlation r=0.330; p<0.001) as well as between albumin values and the Barthel index (Spearman's correlation r=0.210; p<0.001). CONCLUSION: Anemia appears to be a risk factor for HA in inpatients with malnutrition and the observed association between albumin and Hb warrants further research. Geriatric inpatients with anemia should be evaluated in terms of the presence of malnutrition risk and HA.


Asunto(s)
Anemia/diagnóstico , Anemia/epidemiología , Evaluación Geriátrica/estadística & datos numéricos , Hipoalbuminemia/diagnóstico , Hipoalbuminemia/epidemiología , Estado Nutricional , Anciano de 80 o más Años , Anemia/sangre , Comorbilidad , Femenino , Anciano Frágil/estadística & datos numéricos , Evaluación Geriátrica/métodos , Alemania/epidemiología , Hemoglobinas/análisis , Hospitalización/estadística & datos numéricos , Humanos , Hipoalbuminemia/sangre , Masculino , Prevalencia , Factores de Riesgo , Albúmina Sérica/análisis
3.
Z Gerontol Geriatr ; 47(2): 131-5, 2014 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-24619044

RESUMEN

BACKGROUND: There is no difference in medical and nutritional therapy between elderly and young surgical patients. However, based on the high prevalence of malnutrition or a risk for malnutrition and the associated risk for complications, elderly surgical patients should receive special attention. AIM: This article addresses the options in perioperative nutritional therapy and gives an overview on current guidelines and study results. MATERIALS AND METHODS: The article includes a literature review of current national and international guidelines in the field of surgery and geriatrics. Cochrane reviews, systematic reviews, meta-analyses, and significant single studies are also included. RESULTS: Contrary to former approaches, national and international organizations recommend to keep the duration of pre- and postoperative fasting as short as possible. The benefits of nutritional therapy in stabilization and improvement of the nutritional status of surgical patients has already been shown in several patient groups like patients undergoing major abdominal surgeries. For other patients groups, like patients with sepsis, further studies are needed to evaluate the benefit of a perioperative nutritional intervention.


Asunto(s)
Desnutrición/epidemiología , Desnutrición/prevención & control , Terapia Nutricional/estadística & datos numéricos , Atención Perioperativa/estadística & datos numéricos , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/prevención & control , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Terapia Nutricional/métodos , Atención Perioperativa/métodos , Prevalencia , Medición de Riesgo/métodos , Resultado del Tratamiento
4.
J Nutr Health Aging ; 19(8): 812-8, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26412285

RESUMEN

OBJECTIVE: The progression of Alzheimer's disease (AD) is associated with impaired nutritional status. New methods, such as deep brain stimulation (DBS), are currently being tested to decrease the progression of AD. DBS is an approved method in the treatment of Parkinson's disease, and its suitability for the treatment of AD patients is currently under experimental investigation. To evaluate the advantages and disadvantages of this new treatment, it is important to assess potential side effects of DBS regarding the nucleus basalis of Meynert; this new treatment is thought to positively affect cognition and might counteract the deterioration of nutritional status and progressive weight loss observed in AD. This study aims to assess the nutritional status of patients with AD before receiving DBS of the nucleus basalis of Meynert and after 1 year, and to analyze potential associations between changes in cognition and nutritional status. DESIGN: A 1-year phase I proof-of-concept study. SETTING: The Department of Psychiatry and Psychotherapy at the University of Cologne. PARTICIPANTS: We assessed a consecutive sample of patients with mild to moderate AD (n=6) who fulfilled the inclusion criteria and provided written informed consent. INTERVENTION: Bilateral low-frequency DBS of the nucleus basalis of Meynert. MEASUREMENTS: Nutritional status was assessed using a modified Mini Nutritional Assessment, bioelectrical impedance analysis, a completed 3-day food diary, and analysis of serum levels of vitamin B12 and folate. RESULTS: With a normal body mass index (BMI) at baseline (mean 23.75 kg/m²) and after 1 year (mean 24.59 kg/m²), all but one patient gained body weight during the period of the pilot study (mean 2.38 kg, 3.81% of body weight). This was reflected in a mainly stable or improved body composition, assessed by bioelectrical impedance analysis, in five of the six patients. Mean energy intake increased from 1534 kcal/day (min 1037, max 2370) at baseline to 1736 kcal/day (min 1010, max 2663) after 1 year, leading to the improved fulfillment of energy needs in four patients. The only nutritional factors that were associated with changes in cognition were vitamin B12 level at baseline (Spearman's rho = 0.943, p = 0.005) and changes in vitamin B12 level (Spearman's rho = -0.829, p = 0.042). CONCLUSION: Patients with AD that received DBS of the nucleus basalis of Meynert demonstrated a mainly stable nutritional status within a 1-year period. Whether DBS is causative regarding these observations must be investigated in additional studies.


Asunto(s)
Enfermedad de Alzheimer/terapia , Núcleo Basal de Meynert/fisiología , Cognición/fisiología , Estimulación Encefálica Profunda/efectos adversos , Estado Nutricional , Anciano , Enfermedad de Alzheimer/fisiopatología , Composición Corporal , Peso Corporal , Registros de Dieta , Femenino , Ácido Fólico , Humanos , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson/terapia , Proyectos Piloto , Vitamina B 12/sangre
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda